RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'
Tweet Send to a Friend
RBC Capital analyst Luca Issi reiterated a Sector Perform rating and $5.00 price target on WAVE Life Sciences (NASDAQ: WVE).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
